| 12091661 |
Organic compositions to treat HSF1-related diseases |
Gregory Hinkle, Satyanarayana Kuchimanchi, Stuart Milstein, Wenlai Zhou, Ping Zhu +1 more |
2024-09-17 |
| 11524009 |
Combination comprising at least one spliceosome modulator and at least one inhibitor chosen from BCL2 inhibitors, BCL2/BCLxL inhibitors, and BCLxL inhibitors and methods of use |
Daniel Aird, Laura Corson, Ping Zhu, Silvia Buonamici, Peter Smith +1 more |
2022-12-13 |
| 11091761 |
Organic compositions to treat HSF1-related diseases |
Gregory Hinkle, Satyanarayana Kuchimanchi, Stuart Milstein, Wenlai Zhou, Ping Zhu +1 more |
2021-08-17 |
| 10287582 |
Organic compositions to treat HSF1-related diseases |
Gregory Hinkle, Satyanarayana Kuchimanchi, Stuart Milstein, Wenlai Zhou, Ping Zhu +1 more |
2019-05-14 |
| 10023862 |
Organic compositions to treat beta-catenin-related diseases |
Brian Bettencourt, David Bumcrot, Dieter Huesken, Satyanarayana Kuchimanchi, Stuart Milstein +3 more |
2018-07-17 |
| 9540643 |
Organic compositions to treat HSF1-related diseases |
Gregory Hinkle, Satyanarayana Kuchimanchi, Stuart Milstein, Wenlai Zhou, Ping Zhu +1 more |
2017-01-10 |
| 9096637 |
Organic compositions to treat HSF1-related diseases |
Gregory Hinkle, Satyanarayana Kuchimanchi, Stuart Milstein, Wenlai Zhou, Ping Zhu +1 more |
2015-08-04 |
| 8748428 |
Use of a PKC inhibitor |
Walter Schuler, Frank Peter Stegmeier |
2014-06-10 |
| 8623838 |
Organic compositions to treat HSF1-related diseases |
Jinyun Chen, Gregory Hinkle, Satyanarayana Kuchimanchi, Stuart Milstein, Wenlai Zhou +2 more |
2014-01-07 |
| 8507471 |
Biphenylcarboxamide derivatives as hedgehod pathway modulators |
Christine Dierks, Xu Wu |
2013-08-13 |
| 8481509 |
Organic compositions to treat HSF1-related diseases |
Gregory Hinkle, Satyanarayana Kuchimanchi, Stuart Milstein, Wenlai Zhou, Ping Zhu +1 more |
2013-07-09 |
| 8293718 |
Organic compositions to treat HSF1-related diseases |
Gregory Hinkle, Satyanarayana Kuchimanchi, Stuart Milstein, Wenlai Zhou, Ping Zhu +1 more |
2012-10-23 |
| 8268837 |
Use of c-Src inhibitors alone or in combination with STI571 for the treatment of leukaemia |
Nicholas J. Donato, Doriano Fabbro, Paul W. Manley, Jurgen Mestan, Michael Hallek +2 more |
2012-09-18 |
| 8119649 |
Use of c-Src inhibitors alone or in combination with STI571 for the treatment of leukaemia |
Nicholas J. Donato, Doriano Fabbro, Paul W. Manley, Jurgen Mestan, Michael Hallek +2 more |
2012-02-21 |
